日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Diurnal Variations in Serum Uric Acid, Xanthine, and Xanthine Oxidoreductase Activity in Male Patients with Coronary Artery Disease

冠状动脉疾病男性患者血清尿酸、黄嘌呤和黄嘌呤氧化还原酶活性的昼夜变化

Shimizu, Megumi; Naito, Ryo; Sato, Akihiro; Ishiwata, Sayaki; Yatsu, Shoichiro; Shitara, Jun; Matsumoto, Hiroki; Murata, Azusa; Kato, Takao; Suda, Shoko; Hiki, Masaru; Kuwabara, Masanari; Murase, Takayo; Nakamura, Takashi; Kasai, Takatoshi

A Newly Developed Method-Based Xanthine Oxidoreductase Activities in Various Human Liver Diseases

基于新开发方法的多种人类肝脏疾病中黄嘌呤氧化还原酶活性研究

Sato, Ken; Naganuma, Atsushi; Nagashima, Tamon; Arai, Yosuke; Mikami, Yuka; Nakajima, Yuka; Kanayama, Yuki; Murakami, Tatsuma; Uehara, Sanae; Uehara, Daisuke; Yamazaki, Yuichi; Murase, Takayo; Nakamura, Takashi; Uraoka, Toshio

Association of plasma xanthine oxidoreductase activity with vascular endothelial function independent of serum uric acid level: MedCity21 health examination registry

血浆黄嘌呤氧化还原酶活性与血管内皮功能相关,且该关联独立于血清尿酸水平:MedCity21健康体检登记研究

Kurajoh, Masafumi; Fukumoto, Shinya; Akari, Seigo; Murase, Takayo; Nakamura, Takashi; Ihara, Yasutaka; Imai, Takumi; Nagata, Yuki; Morioka, Tomoaki; Mori, Katsuhito; Imanishi, Yasuo; Watanabe, Toshio; Emoto, Masanori

Systemic Endothelial Function, Plasma Xanthine Oxidoreductase Activity, and Blood Pressure Variability in Patients with Stable Coronary Artery Disease

稳定型冠状动脉疾病患者的系统性内皮功能、血浆黄嘌呤氧化还原酶活性和血压变异性

Hiraga, Takashi; Saito, Yuichi; Tateishi, Kazuya; Mori, Naoto; Murase, Takayo; Nakamura, Takashi; Akari, Seigo; Saito, Kan; Kitahara, Hideki; Kobayashi, Yoshio

Associations of circulating xanthine oxidoreductase activity with cardiometabolic risk markers in overweight and obese Japanese men: a cross-sectional pilot study

循环黄嘌呤氧化还原酶活性与超重和肥胖日本男性心血管代谢风险标志物之间的关联:一项横断面试点研究

Kosaki, Keisei; Yokota, Atsumu; Tanahashi, Koichiro; Myoenzono, Kanae; Park, Jiyeon; Yoshikawa, Toru; Yoshida, Yasuko; Murase, Takayo; Akari, Seigo; Nakamura, Takashi; Maeda, Seiji

Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice

黄嘌呤氧化还原酶抑制剂托吡罗司他对于糖尿病肥胖小鼠体重的影响

Nakamura, Takashi; Nampei, Mai; Murase, Takayo; Satoh, Etsuko; Akari, Seigo; Katoh, Noriaki; Mizukami, Hiroki

Time-dependent changes in plasma xanthine oxidoreductase during hospitalization of acute heart failure

急性心力衰竭住院期间血浆黄嘌呤氧化还原酶的时间依赖性变化

Okazaki, Hirotake; Shirakabe, Akihiro; Matsushita, Masato; Shibata, Yusaku; Shigihara, Shota; Sawatani, Tomofumi; Tani, Kenichi; Kiuchi, Kazutaka; Otsuka, Yusuke; Murase, Takayo; Nakamura, Takashi; Kobayashi, Nobuaki; Hata, Noritake; Asai, Kuniya; Shimizu, Wataru

Plasma xanthine oxidoreductase activity in Japanese patients with type 2 diabetes across hospitalized treatment

日本2型糖尿病患者住院治疗期间血浆黄嘌呤氧化还原酶活性

Kawachi, Yusuke; Fujishima, Yuya; Nishizawa, Hitoshi; Nagao, Hirofumi; Nakamura, Takashi; Akari, Seigo; Murase, Takayo; Taya, Naohiro; Omori, Kazuo; Miyake, Akimitsu; Fukuda, Shiro; Takahara, Mitsuyoshi; Kita, Shunbun; Katakami, Naoto; Maeda, Norikazu; Shimomura, Iichiro

Association between plasma xanthine oxidoreductase activity and in-hospital outcomes in patients with stable coronary artery disease after percutaneous coronary intervention

血浆黄嘌呤氧化还原酶活性与稳定型冠状动脉疾病患者经皮冠状动脉介入治疗后住院结局的相关性

Sato, Ryota; Akita, Keitaro; Ikoma, Takenori; Iguchi, Keisuke; Murase, Takayo; Nakamura, Takashi; Akari, Seigo; Mogi, Satoshi; Naruse, Yoshihisa; Ohtani, Hayato; Maekawa, Yuichiro

Impact of plasma xanthine oxidoreductase activity in patients with heart failure with preserved ejection fraction

血浆黄嘌呤氧化还原酶活性对射血分数保留型心力衰竭患者的影响

Watanabe, Ken; Watanabe, Tetsu; Otaki, Yoichiro; Shishido, Tetsuro; Murase, Takayo; Nakamura, Takashi; Kato, Shigehiko; Tamura, Harutoshi; Nishiyama, Satoshi; Takahashi, Hiroki; Arimoto, Takanori; Watanabe, Masafumi